A detailed history of State Street Corp transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, State Street Corp holds 1,179,514 shares of PRCT stock, worth $104 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,179,514
Previous 1,113,339 5.94%
Holding current value
$104 Million
Previous $68 Million 38.93%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.31 - $84.99 $3.73 Million - $5.62 Million
66,175 Added 5.94%
1,179,514 $94.5 Million
Q2 2024

Aug 14, 2024

BUY
$45.73 - $69.19 $2.1 Million - $3.17 Million
45,837 Added 4.29%
1,113,339 $68 Million
Q1 2024

May 15, 2024

SELL
$40.38 - $50.75 $729,383 - $916,697
-18,063 Reduced 1.66%
1,067,502 $52.8 Million
Q4 2023

Feb 14, 2024

BUY
$24.89 - $43.41 $1.34 Million - $2.34 Million
53,854 Added 5.22%
1,085,565 $45.5 Million
Q3 2023

Nov 14, 2023

SELL
$30.02 - $38.81 $931,190 - $1.2 Million
-31,019 Reduced 2.92%
1,031,711 $33.9 Million
Q2 2023

Aug 14, 2023

BUY
$26.7 - $37.02 $7.08 Million - $9.81 Million
265,072 Added 33.23%
1,062,730 $37.6 Million
Q1 2023

May 15, 2023

BUY
$26.64 - $39.74 $2.39 Million - $3.56 Million
89,586 Added 12.65%
797,658 $22.7 Million
Q4 2022

Feb 14, 2023

BUY
$38.78 - $46.78 $1.76 Million - $2.13 Million
45,510 Added 6.87%
708,072 $29.4 Million
Q3 2022

Nov 15, 2022

BUY
$30.9 - $50.65 $6.42 Million - $10.5 Million
207,804 Added 45.7%
662,562 $27.5 Million
Q2 2022

Aug 15, 2022

BUY
$29.23 - $44.45 $9.96 Million - $15.1 Million
340,596 Added 298.34%
454,758 $14.9 Million
Q1 2022

May 16, 2022

BUY
$16.89 - $35.74 $495,957 - $1.05 Million
29,364 Added 34.63%
114,162 $4 Million
Q4 2021

Feb 14, 2022

BUY
$24.6 - $46.29 $2.09 Million - $3.93 Million
84,798 New
84,798 $2.12 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.95B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.